A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants

Clinical trial NCT01458210 · COMPLETED

Trial details

NCT number: NCT01458210
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2011-10-01
Primary completion: 2012-02-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.